BCRABL; tyrosine kinases; inhibitors; chronic myelogenous leukemia; review.
bcrabl；酪氨酸激酶；抑制剂；慢性粒细胞白血病；综述。
Objective:In order to know the alternation of plasma lipids in chronic myelogenous leukemia(CML).
目的：了解慢性粒细胞白血病（CML）患者的血脂变化规律。
Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.
相对于急性白血病，慢性淋巴细胞白血病和慢性粒细胞性白血病通常进展缓慢。
Finally, phagocyte precursors may undergo malignant transformation, which results in acute or chronic myelogenous leukemia.
到最后，吞噬细胞前体可能发生恶变，导致急性或慢性骨髓性白血病。
Such massive splenomegaly is usually indicative of some myeloproliferative disease such as chronic myelogenous leukemia or myelofibrosis.
这样的脾肿大通常预示有骨髓增生型疾病，例如慢性髓性白血病或骨髓纤维化。
Objective to carry out health education of patients with chronic myelogenous leukemia to improve patients self - conservancy and life quality.
目的对慢性粒细胞白血病患者进行健康教育，提高患者的自我保健能力和生活质量。
To summarize and analyze curative effect on 52 cases of Chronic Myelogenous Leukemia (CML) by clearing away liver fire and dispersing blood stasis.
总结分析以清肝化瘀法为主治疗慢性粒细胞白血病5 2例的远期疗效。
Conclusion The combination regimen of HHT and Ara cis effective and economical in patient with late chronic-phase chronic myelogenous leukemia(CML).
结论高三尖杉酯碱联合低剂量阿糖胞苷治疗慢粒白血病急变简便，经济，有效。
The drug blocks a mutant protein that causes chronic myelogenous leukemia (CML), becoming the first chemotherapy to specifically target cancer cells.
该药可以阻断引起慢性髓细胞性白血病（CML）的突变蛋白，成为第一个特异靶向癌细胞的化学药。
Objective To determine the distribution of reticulin fibre and megakaryocyte in bone marrow biopsy(Trephine biopsy)of chronic myelogenous leukemia (CML).
目的为了解慢性粒细胞白血病（CML）骨髓中巨核细胞和网状纤维的增生情况及其关系。
Objective The purpose of this study is to find the relationship and significance between the expression of JWA gene and chronic myelogenous leukemia (CML).
目的探讨JWA基因表达与慢性粒细胞性白血病（CML）的相关意义。
Objective to investigate the effect of autologous dendritic cells (DC) to activate t lymphocytes and purify bone marrow of chronic myelogenous leukemia (CML).
目的考察慢性粒细胞白血病(cml)树突状细胞(DC)刺激自体骨髓t细胞，清除白血病细胞的作用。
Objective:To study on relationship between of BCR/ABL fusion gene expression and TCM syndrome classification in the patient of chronic myelogenous leukemia(CML).
目的：探讨慢性粒细胞白血病（CML）患者BCR/ABL融合基因表达与中医辨证分型的关系。
Objective To investigate the association of the programmed cell death (PCD) regulating proteins with the acute transformation of chronic myelogenous leukemia (CML).
目的了解细胞程序死亡(PCD)与慢性髓细胞性白血病(CML)急变的关系。
"Chronic" leukemias have few or no blast cells. "chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.
“慢性”白血病少有或几乎没有母细胞。与急性白血病相比，“慢性淋巴细胞性白血病”和“慢性髓细胞性白血病”通常进程相对缓慢。
In chronic myelogenous leukemia (CML), the leukemia cell that starts the disease makes blood cells (red cells, white cells and platelets) that function almost like normal cells.
在慢粒中，起始的白血病细胞产生功能正常的血细胞(红细胞、白细胞、血小板)。
Interferons, a cytokines family, a re capable of producing multiplex biological effects, and have remarkable curative effects on hair cell leukemia and chronic myelogenous leukemia.
干扰素是能够产生多向性生物学效应的细胞因子家族，在毛细胞白血病、慢性髓细胞性白血病治疗中疗效显著。
Interferons, a cytokines family, a re capable of producing multiplex biological effects, and have remarkable curative effects on hair cell leukemia and chronic myelogenous leukemia.
干扰素是能够产生多向性生物学效应的细胞因子家族，在毛细胞白血病、慢性髓细胞性白血病治疗中疗效显著。
应用推荐